June 26, 2018 | Med Tech, Wilmington Healthcare, healthcare
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.
Wilmington Healthcare appoints new Commercial Director
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.
In her new post, Sue will lead Wilmington Healthcare’s MedTech services, which include healthcare data, education, information and analytics. She will also oversee a number of key accounts.
Having worked in sales, marketing and business management roles in healthcare for nearly 20 years, Sue has joined Wilmington Healthcare from Veeva Systems, where she was Global Director for Customer Success.
Prior to that, she was Global Strategic Account Director for Zinc Ahead Ltd, where she was the global point of contact for key corporate contacts. The company was acquired by Veeva in September 2015.
Other roles that Sue has held include Product Manager, Anaesthesia & Critical Care, UK, for Baxter Healthcare UK, responsible for the company’s pharmaceutical and medical devices portfolio.
Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Having worked in sales, marketing and business management roles within the healthcare industry for nearly 20 years, Sue will be a great asset to the MedTech team.
“Medtech is a key sector within our portfolio and Sue will play a key role in helping our clients to better understand the challenges they face, exploit their knowledge and expertise, and optimise their business success.”
Ends
Notes to Editors
For more information, please contact: Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com
About Wilmington Healthcare and Wilmington plc
Wilmington Healthcare within the UK, incorporates HSJ, Binley’s, OnMedica, and Wellards . A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com.
Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Paul Rowe to lead intelligence tool that allows Industry to gain the complete picture of their changing NHS customer base and employ precision planning to access target customers and markets.
The recently published operational planning guidance describes what the NHS needs to achieve this year. Wilmington Healthcare’s Oli Hudson explores some of its critical themes and what they mean for...
With a stormy outlook predicted for health and care, Wilmington Healthcare’s Oli Hudson looks at the five critical shifts that pharma should focus on as it navigates its way through...
As well as creating new structures, the reforms underway within the NHS will see a considerable movement of people and power across the new Integrated Care Systems. Wilmington Healthcare’s Victoria...
As the government announces a delay to a new GP data sharing initiative amid privacy concerns, Gareth Thomas, Managing Director of Wilmington Healthcare, explains why industry must move fast to...
Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare
Oli Hudson, Content Director at Wilmington Healthcare, takes a look at the new groups of providers that are expected to play a pivotal role in integrating care.
Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care
Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs
Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas